# BeyondSpring Inc.: Form D filing

BeyondSpring Inc., a biotechnology company in New York, NY, filed a Form D with the SEC in 2017. The latest, on March 21, 2017, reports $7.2 million sold of a $7.2 million offering to 1 investor.

Find out what BeyondSpring Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20BeyondSpring%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=BeyondSpring%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fbeyondspring-inc-1677940)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20BeyondSpring%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=BeyondSpring%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fbeyondspring-inc-1677940)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 28 Liberty Street, 39th Floor, New York, NY, 10005
- Phone: (646) 305-6387
- Industry: Biotechnology
- Entity type: Other (Exempted Company)
- Incorporated in: Delaware
- Year incorporated: 2014
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1677940

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 21, 2017 | New notice | $7,221,001 | $7,221,001 | $0 | 1 | Mar 14, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1677940/000114036117012842/0001140361-17-012842-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Quanqi Song | Director |  |
| Ramon Kenneth Mohanlal | Executive Officer |  |
| Lan Huang | Executive Officer, Director |  |
| Mulong Liu | Director |  |
| Richard A. Brand | Executive Officer |  |
| Christine Y. Zhao | Director |  |
| G. Kenneth Lloyd | Executive Officer |  |
| Yanbin Xie | Director |  |
| Nanxing He | Director |  |
| Gordon L. Schooley | Executive Officer |  |
| Matthew Kirkby | Director |  |

## Other biotechnology companies in New York that filed recently

- [Swep Bio, Inc.](https://specstream.ai/data/form-d/company/swep-bio-inc-2159106) $2.5 million · Oct 29, 2026
- [Hypercell Technologies Inc.](https://specstream.ai/data/form-d/company/hypercell-technologies-inc-1882357) $3 million · Oct 14, 2026
- [CAD Therapeutics, Inc.](https://specstream.ai/data/form-d/company/cad-therapeutics-inc-2157566) $4 million · Oct 2, 2026
- [Vicora, Inc.](https://specstream.ai/data/form-d/company/vicora-inc-2091847) $2.3 million · Sep 18, 2026
- [GevRx Nutraceuticals, Inc.](https://specstream.ai/data/form-d/company/gevrx-nutraceuticals-inc-2156105) $300,000 · Sep 18, 2026
- [Episteme Prognostics, Inc.](https://specstream.ai/data/form-d/company/episteme-prognostics-inc-1902402) $5.1 million · Sep 4, 2026

[Every Form D from the week of Mar 20, 2017](https://specstream.ai/data/form-d/week/2017-03-20) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what BeyondSpring Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).